Schedule 13D ownership disclosure

SIGA PHARMACEUTICALS INC

Security class unavailable · CUSIP: 826917106

Event date: 2020-02-24

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,472,909
Percent of class
4.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001013594-20-000199
Form type
SC 13D/A
Filer
ESOPUS CREEK VALUE SERIES FUND LP - SERIES A
CIK
CIK 1336198
Filed
Feb 25, 2020
Reporting period
Feb 24, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub